Literature DB >> 25553970

Intensity modulated radiation therapy in nasopharyngeal carcinoma.

S Haberer-Guillerm1, E Touboul2, F Huguet2.   

Abstract

Radiation therapy (with associated chemotherapy) is the standard treatment for nasopharyngeal carcinoma. Conformal intensity-modulated radiation therapy is a new and particularly interesting technique for these tumors, due to their complex volumes close to many critical organs. Better dosimetric results and improved protection of adjacent healthy tissue have been shown compared with conventional 2D or 3D radiation therapy, with significantly reduced side-effects, notably xerostomia. Excellent local control rates have been reported.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Conformal intensity-modulated radiation therapy; Late effects; Nasopharyngeal carcinoma; Target volumes; Xerostomia

Mesh：

Year:  2014        PMID： 25553970     DOI： 10.1016/j.anorl.2014.02.008

Source DB:  PubMed          Journal:  Eur Ann Otorhinolaryngol Head Neck Dis        ISSN： 1879-7296            Impact factor:   2.080


  13 in total

Review 1.  The evolution of nasopharyngeal carcinoma staging.

Authors:  Rui Guo; Yan-Ping Mao; Ling-Long Tang; Lei Chen; Ying Sun; Jun Ma
Journal:  Br J Radiol       Date:  2019-07-12       Impact factor: 3.039

2.  Parotid Gland Stem Cell Preservation during Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Dosimetric Analysis and Feasibility.

Authors:  Lirong Zheng; Qiaoli Mei; Yuxiang Gao; Fenglei Du; Lin Xiao; Gangfeng Wu
Journal:  J Oncol       Date:  2022-07-12       Impact factor: 4.501

3.  Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma.

Authors:  Ge Yan; Yan Feng; Mingyao Wu; Chao Li; Yiran Wei; Li Hua; Guoqi Zhao; Zhekai Hu; Shengyu Yao; Lingtong Hou; Xuming Chen; Qianqian Liu; Qian Huang
Journal:  Radiat Oncol       Date:  2022-06-27       Impact factor: 4.309

4.  Effect of Standardized Nutritional Intervention in Patients with Nasopharyngeal Carcinoma Receiving Radiotherapy Complicated with Diabetes Mellitus.

Authors:  Yuhong Ge
Journal:  Dis Markers       Date:  2022-06-15       Impact factor: 3.464

5.  Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.

Authors:  Ryan Anthony F Agas; Kelvin Ken L Yu; Paolo G Sogono; Lester Bryan A Co; J C Kennetth M Jacinto; Warren R Bacorro; Michael Benedict A Mejia
Journal:  J Glob Oncol       Date:  2019-02

6.  The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era.

Authors:  Ling-Long Tang; Shao-Bo Liang; Cheng-Long Huang; Fan Zhang; Cheng Xu; Yan-Ping Mao; Li Tian; Ai-Hua Lin; Li Li; Ying Sun; Jun Ma
Journal:  Cancer Med       Date:  2019-04-04       Impact factor: 4.452

7.  Application of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma.

Authors:  Hao Yan; Xiaoming Cao; Jinmei Wang
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

8.  Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.

Authors:  Min Kang; Pingting Zhou; Guisheng Li; Haolin Yan; Guosheng Feng; Meilian Liu; Jinxian Zhu; Rensheng Wang
Journal:  Oncotarget       Date:  2017-08-02

9.  Pretreatment Nomograms for Local and Regional Recurrence after Radical Radiation Therapy for Primary Nasopharyngeal Carcinoma.

Authors:  Fo-Ping Chen; Li Lin; Zhen-Yu Qi; Guan-Qun Zhou; Rui Guo; Jiang Hu; Ai-Hua Lin; Jun Ma; Ying Sun
Journal:  J Cancer       Date:  2017-08-03       Impact factor: 4.207

Review 10.  Six fractions weekly as accelerated fraction radiotherapy: Is it applicable for nasopharyngeal cancer? A review.

Authors:  Arundito Widikusumo; Schandra Purnamawati
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.